|
| |
| | Cyberbotanica: Paclitaxel (Taxol) & Docetaxel (Taxotere) |
 | | aclitaxel and docetaxel are taxoid drugs extracted from the bark of the Pacific yew and the needles of the English yew, respectively. | | | Docetaxel has been trademarked as Taxotere by Rhone-Poulenc Rorer as an investigational drug. | | | Anemia and bone and muscle pain were also common side effects. |
|
http://biotech.icmb.utexas.edu/botany/tax.html
(347 words)
|
|
| |
| | MedlinePlus Drug Information: Docetaxel (Systemic) |
| | Docetaxel is to be administered only by or under the immediate supervision of your doctor. | | | While you are being treated with docetaxel, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. | | | Before you begin treatment with docetaxel, you and your doctor should talk about the good this medicine will do as well as the risks of using it. |
|
http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202920.html
(1749 words)
|
|
| |
| | Docetaxel - Taxotere - Chemotherapy Drugs - Chemo |
| | Docetaxel - Taxotere - Chemotherapy Drugs - Chemo | | | You will be checked regularly by your health care professional while you are taking docetaxel, to monitor side effects and check your response to therapy. | | | They can prescribe medications and/or offer other suggestions that are effective in managing such problems. |
|
http://www.chemocare.com/BIO/docetaxel.asp
(1581 words)
|
|
| |
| | docetaxel news articles |
| | Taxotere (docetaxel) is the first and only licensed chemotherapy drug to offer improved quality of life, less pain and a survival benefit for men with advanced... | | | ARQ 501, partnered with Roche, is in a Phase 1 clinical trial as monotherapy and in two Phase 1b trials in combination therapy with docetaxel and gemcitabine. | | | New Clinical Study of Phenoxodiol as Chemo-sensitizer for... |
|
http://www.mongabay.com/drugs/drugs/docetaxel.html
(7118 words)
|
|
| |
| | PRESS RELEASE Thalomid(R) in Major Peer-Reviewed Journal Publication of Clinical Data From Randomized Phase II Trial in ... |
| | This trial used thalidomide in combination with docetaxel (taxotere) versus docetaxel alone in patients with metastatic androgen-independent prostate cancer (AIPC), and is published in the July 1, 2004 issue of the Journal of Clinical Oncology (JCO), a major peer-reviewed journal. | | | This was an open-label, randomized, phase II study of docetaxel plus thalidomide versus the docetaxel alone in patients with metastatic AIPC. | | | "This Phase II clinical data demonstrated that thalidomide in combination with docetaxel may be a future option in the clinical treatment of androgen-independent prostate cancer," said Dr. Sol J. Barer, Ph.D., President and Chief Operating Officer of Celgene Corporation. |
|
http://www.marketwire.com/mw/release_html_b1?release_id=69254
(1309 words)
|
|
| |
| | Disease Category Listing (36): Prostate Cancer |
| | This study is open to men age 18 and older who have prostate cancer that has spread to the bone, are pain-free or in mild pain, and also have rising serum PSA values. |
|
http://www.centerwatch.com/patient/studies/cat36.html
(9793 words)
|
|
| |
| | Docetaxel (Taxotere)Clinical trials, 21CEC |
| | Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer | | | Docetaxel in Treating Patients Who Have Undergone Surgery for Prostate Cancer | | | Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer |
|
http://www.21cecpharm.com/dx/clinic
(1292 words)
|
|
| |
| | MedlinePlus Drug Information: Docetaxel |
| | tell your doctor and pharmacist if you are allergic to docetaxel or any other drugs. | | | This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information. | | | If you experience any of the following symptoms, call your doctor immediately: shortness of breath, facial flushing, fever, chest pain, dizziness, lightheadedness, or skin rash. |
|
http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a696031.html
(519 words)
|
|
| |
| | Clinical Trial: Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone ... |
| | PURPOSE: This phase II trial is studying how well giving docetaxel with imatinib mesylate works in treating patients with androgen-independent prostate cancer and bone metastases that progressed while receiving docetaxel and a placebo on clinical trial MDA-ID-030008. | | | Determine the quality of life of patients treated with this crossover regimen. | | | Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 |
|
http://clinicaltrials.gov/ct/show/NCT00084825?order=31
(594 words)
|
|
| |
| | Cancer information on MedicineNet.com |
| | Our docetaxel, Taxotere Main Article provides a comprehensive look at the who, what, when and how of docetaxel | | | MedicineNet Home > Medications A-Z List > Cancer Home Page > docetaxel | | | Please consult your healthcare provider before beginning any course of supplementation or treatment. |
|
http://www.medicinenet.com/docetaxel
(159 words)
|
|
| |
| | Product Label |
| | Y-10, N-2, A-1 Do the data on median time to progression, morphine analgesic use, and mean change in performance status from baseline to last assessment presented in this sNDA adequately demonstrate that therapy with docetaxel 75 mg/m2 in second line treatment of NSCLC confers clinical benefit? | | | Y-13, N-0, A-0 Is docetaxel 75 mg/m2 approvable "for the treatment of patients with locally advanced or metastatic NSCLC after failure of prior chemotherapy? | | | Are the medain and 1-year survival data presented for docetaxel 75 mg/m2 adequate to demonstrate a survival benefit associated with this docetaxel dose in second line treatment of NSCLC? |
|
http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=143
(190 words)
|
|
| |
| | Docetaxel - Wikipedia, the free encyclopedia |
| | Docetaxel is a chemotherapy drug used in the treatment of cancer. | | | It has been developed after the related drug, paclitaxel. | | | Tax-deductibility of donations - Current budget - Daily report |
|
http://en.wikipedia.org/wiki/Docetaxel
(161 words)
|
|
| |
| | DG DISPATCH - LUNG CANCER: Neoadjuvant Docetaxel (Taxotere) Improves Life Expectancy In Locally Advanced Lung Cancer |
| | The use of docetaxel did not have a deleterious effect on the ability of patients to receive definitive therapy. | | | TOKYO, JAPAN -- September 12, 2000 -- The use of docetaxel (Taxotere) as neoadjuvant therapy prior to local treatment improves survival over local treatment alone in patients with locally advanced non-small cell lung cancer (NSCLC). | | | Mattson said the results demonstrate that docetaxel administered as a single agent is effective and generally well-tolerated when used as a neoadjuvant treatment in stage III NSCLC. |
|
http://www.pslgroup.com/dg/1e092e.htm
(514 words)
|
|
| |
| | Docetaxel induced cardiotoxicity -- SHIMOYAMA et al. 86 (2): 219 -- Heart |
| | Ten consecutive patients with breast cancer having skin metastasis who received docetaxel were investigated. | | | reasonable to consider that docetaxel may induce contractile dysfunction | | | docetaxel exerts its actions by stabilising microtubules, it is |
|
http://heart.bmjjournals.com/cgi/content/full/86/2/219
(514 words)
|
|
| |
| | PillsPrescriptionRX.com - docetaxel |
| | The latest news on Docetaxel and advances in cancer therapies, treatment, and prevention, reported from the American Society of Clinical Oncology. | | | JoltSearch has results for docetaxel and much more! | | | Find results for docetaxel and anything else you are looking for instantly! |
|
http://www.pillsprescriptionrx.com/d/docetaxel.html
(249 words)
|
|
| |
| | Aventis Oncology: Overview |
| | Today, these agents play a major role throughout the world in the treatment of certain types of cancer, as well as in the management of side effects. | | | That's why we strive for new solutions that will improve the lives of cancer patients. | | | We've been pioneers in the development of new cytotoxic agents, including Taxotere® (docetaxel) Injection Concentrate, and supportive-care products, such as Anzemet® (dolasetron mesylate) injection/tablets. |
|
http://www.aventisoncology.com
(331 words)
|
|
|
